{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:57:09Z","timestamp":1784901429275,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572297"],"award-info":[{"award-number":["81572297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gallbladder cancer (GBC) is the most common type of biliary tract cancer worldwide. Long noncoding RNAs (lncRNAs) play essential roles in physiological and pathological development. LncRNA <jats:italic>MEG3<\/jats:italic>, a tumor suppressor, has been reported to play important roles in some cancers, but the role of MEG3 in GBC remains largely unknown. The purpose of the present study was to explore the role of MEG3 in proliferation and invasion and the potential molecular mechanism in GBC. We found that MEG3 was downregulated in GBC tissues and cells, and low expression of MEG3 was correlated with poor prognostic outcomes in patients. Overexpression of MEG3 inhibited GBC cell proliferation and invasion, induced cell apoptosis and decreased tumorigenicity in nude mice. Moreover, we found that MEG3 was associated with EZH2 and attenuated EZH2 by promoting its ubiquitination. Furthermore, MEG3 executed its functions via EZH2 to regulate the downstream target gene LATS2. Taken together, these findings suggest that MEG3 is an effective target for GBC therapy and may facilitate the development of lncRNA-directed diagnostics and therapeutics against GBC.<\/jats:p>","DOI":"10.1038\/s41419-018-1064-1","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T08:28:51Z","timestamp":1538555331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Longyang","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"1064_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu, A. X., Hong, T. S., Hezel, A. F. & Kooby, D. A. Current management of gallbladder carcinoma. Oncologist 15, 168\u2013181 (2010).","journal-title":"Oncologist"},{"key":"1064_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy, A. et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J. Surg. Oncol. 98, 485\u2013489 (2008).","journal-title":"J. Surg. Oncol."},{"key":"1064_CR3","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1572-0241.2000.02070.x","volume":"95","author":"S Sheth","year":"2000","unstructured":"Sheth, S., Bedford, A. & Chopra, S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am. J. Gastroenterol. 95, 1402\u20131410 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"1064_CR4","doi-asserted-by":"publisher","first-page":"967472","DOI":"10.1155\/2015\/967472","volume":"2015","author":"R Kanthan","year":"2015","unstructured":"Kanthan, R., Senger, J. L., Ahmed, S. & Kanthan, S. C. Gallbladder cancer in the 21st century. J. Oncol. 2015, 967472 (2015).","journal-title":"J. Oncol."},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101\u2013108 (2012).","journal-title":"Nature"},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904\u2013914 (2011).","journal-title":"Mol. Cell"},{"key":"1064_CR7","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1038\/onc.2015.340","volume":"35","author":"X Xue","year":"2016","unstructured":"Xue, X. et al. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene 35, 2746\u20132755 (2016).","journal-title":"Oncogene"},{"key":"1064_CR8","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-13-3447","volume":"74","author":"LM Barnhill","year":"2014","unstructured":"Barnhill, L. M. et al. High expression of CAI2, a 9p21-embedded long non-coding RNA, contributes to advanced stage neuroblastoma. Cancer Res. 74, 3753\u20133763 (2014).","journal-title":"Cancer Res."},{"key":"1064_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1158\/0008-5472.CAN-13-3159","volume":"74","author":"JR Prensner","year":"2014","unstructured":"Prensner, J. R. et al. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res. 74, 1651\u20131660 (2014).","journal-title":"Cancer Res."},{"key":"1064_CR10","doi-asserted-by":"crossref","first-page":"47957","DOI":"10.18632\/oncotarget.18204","volume":"8","author":"Q Cai","year":"2017","unstructured":"Cai, Q. et al. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression. Oncotarget 8, 47957\u201347968 (2017).","journal-title":"Oncotarget"},{"key":"1064_CR11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/onc.2013.187","volume":"33","author":"FM Davis","year":"2014","unstructured":"Davis, F. M. et al. Induction of epithelial\u2013mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene 33, 2307\u20132316 (2014).","journal-title":"Oncogene"},{"key":"1064_CR12","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/onc.2013.210","volume":"33","author":"P Chandrakesan","year":"2014","unstructured":"Chandrakesan, P. et al. Utility of a bacterial infection model to study epithelial\u2013mesenchymal transition, mesenchymal\u2013epithelial transition or tumorigenesis. Oncogene 33, 2639\u20132654 (2014).","journal-title":"Oncogene"},{"key":"1064_CR13","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1158\/0008-5472.CAN-09-1618","volume":"69","author":"T Tsuji","year":"2009","unstructured":"Tsuji, T., Ibaragi, S. & Hu, G. Epithelial\u2212mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 69, 7135\u20137139 (2009).","journal-title":"Cancer Res."},{"key":"1064_CR14","doi-asserted-by":"publisher","first-page":"e1583","DOI":"10.1038\/cddis.2014.541","volume":"6","author":"MZ Ma","year":"2015","unstructured":"Ma, M. Z. et al. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 6, e1583 (2015).","journal-title":"Cell Death Dis."},{"key":"1064_CR15","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1158\/0008-5472.CAN-15-3047","volume":"76","author":"MZ Ma","year":"2016","unstructured":"Ma, M. Z. et al. Long noncoding RNA GCASPC, a target of miR-17-3p, negatively regulates Pyruvate Carboxylase-dependent cell proliferation in gallbladder cancer. Cancer Res. 76, 5361\u20135371 (2016).","journal-title":"Cancer Res."},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"e2225","DOI":"10.1038\/cddis.2016.126","volume":"7","author":"W Li","year":"2016","unstructured":"Li, W. et al. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death Dis. 7, e2225 (2016).","journal-title":"Cell Death Dis."},{"key":"1064_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.molcel.2013.01.010","volume":"49","author":"F Yang","year":"2013","unstructured":"Yang, F. et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell 49, 1083\u20131096 (2013).","journal-title":"Mol. Cell"},{"key":"1064_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molcel.2013.11.004","volume":"53","author":"F Yang","year":"2014","unstructured":"Yang, F., Zhang, H., Mei, Y. & Wu, M. Reciprocal regulation of HIF-1alpha and lincRNA-p21 modulates the Warburg effect. Mol. Cell 53, 88\u2013100 (2014).","journal-title":"Mol. Cell"},{"key":"1064_CR19","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s11033-012-2261-0","volume":"40","author":"IA Voutsadakis","year":"2013","unstructured":"Voutsadakis, I. A. Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer. Mol. Biol. Rep. 40, 2019\u20132034 (2013).","journal-title":"Mol. Biol. Rep."},{"key":"1064_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12032-014-0093-6","volume":"31","author":"MJ Zhou","year":"2014","unstructured":"Zhou, M. J., Chen, F. Z. & Chen, H. C. Ubiquitination involved enzymes and cancer. Med. Oncol. 31, 93 (2014).","journal-title":"Med. Oncol."},{"key":"1064_CR21","doi-asserted-by":"publisher","first-page":"28511","DOI":"10.1074\/jbc.M111.240515","volume":"286","author":"SC Wu","year":"2011","unstructured":"Wu, S. C. & Zhang, Y. Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of enhancer of Zeste 2 (Ezh2) regulates its stability*. J. Biol. Chem. 286, 28511\u201328519 (2011).","journal-title":"J. Biol. Chem."},{"key":"1064_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.canlet.2016.06.019","volume":"380","author":"SH Wang","year":"2016","unstructured":"Wang, S. H. et al. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Cancer Lett. 380, 122\u2013133 (2016).","journal-title":"Cancer Lett."},{"key":"1064_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biochi.2016.11.007","volume":"132","author":"A Khandelwal","year":"2017","unstructured":"Khandelwal, A., Malhotra, A., Jain, M., Vasquez, K. M. & Jain, A. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis. Biochimie 132, 152\u2013160 (2017).","journal-title":"Biochimie"},{"key":"1064_CR24","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/JME-12-0008","volume":"48","author":"Y Zhou","year":"2012","unstructured":"Zhou, Y., Zhang, X. & Klibanski, A. MEG3 noncoding RNA: a tumor suppressor. J. Mol. Endocrinol. 48, R45\u2013R53 (2012).","journal-title":"J. Mol. Endocrinol."},{"key":"1064_CR25","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1038\/onc.2017.14","volume":"36","author":"C Zhou","year":"2017","unstructured":"Zhou, C. et al. LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1\u03b1 translation. Oncogene 36, 3878\u20133889 (2017).","journal-title":"Oncogene"},{"key":"1064_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3892\/or.2017.5828","volume":"38","author":"L Li","year":"2017","unstructured":"Li, L. et al. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis. Oncol. Rep. 38, 1383\u20131392 (2017).","journal-title":"Oncol. Rep."},{"key":"1064_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13046-016-0472-2","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Lin, Z., Gao, Y. & Yao, T. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer. J. Exp. Clin. Cancer Res. 36, 5 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1064_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","volume":"7","author":"M Sauvageau","year":"2010","unstructured":"Sauvageau, M. & Sauvageau, G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 7, 299\u2013313 (2010).","journal-title":"Cell Stem Cell"},{"key":"1064_CR29","doi-asserted-by":"publisher","first-page":"27757","DOI":"10.1074\/jbc.M804442200","volume":"283","author":"P Joshi","year":"2008","unstructured":"Joshi, P. et al. Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2. J. Biol. Chem. 283, 27757\u201327766 (2008).","journal-title":"J. Biol. Chem."},{"key":"1064_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1158\/1078-0432.CCR-17-0605","volume":"24","author":"Q Chen","year":"2017","unstructured":"Chen, Q. et al. Long non-coding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT\/beta-Catenin pathway by scaffolding EZH2. Clin. Cancer Res. 24, 684\u2013695 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1064_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cdd.2016.95","volume":"24","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Cell Death Differ. 24, 59\u201371 (2017).","journal-title":"Cell Death Differ."},{"key":"1064_CR32","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.4161\/cc.9.19.13386","volume":"9","author":"S Visser","year":"2010","unstructured":"Visser, S. & Yang, X. LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle 9, 3892\u20133903 (2010).","journal-title":"Cell Cycle"},{"key":"1064_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13046-017-0622-1","volume":"36","author":"Y Gao","year":"2017","unstructured":"Gao, Y. et al. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 36, 161 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1064_CR34","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1038\/onc.2017.240","volume":"36","author":"Y Guo","year":"2017","unstructured":"Guo, Y. et al. miR-302\/367\/LATS2\/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance. Oncogene 36, 6336\u20136347 (2017).","journal-title":"Oncogene"},{"key":"1064_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cellsig.2016.02.012","volume":"28","author":"L Hoa","year":"2016","unstructured":"Hoa, L. et al. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling. Cell. Signal. 28, 488\u2013497 (2016).","journal-title":"Cell. Signal."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1064-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1064-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1064-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:20:57Z","timestamp":1671538857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1064-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1064-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the Human Ethics Committee of Xinhua Hospital. Informed consent was obtained from every patient. The animal experiments were approved by the Animal Care and Use committee of Xinhua Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"1017"}}